Authors: Wyllie, MG

Citation: Mg. Wyllie, Clinical trials design: protocols and endpoints, INT J IMPOT, 12, 2000, pp. S53-S58

Authors: Wyllie, MG

Citation: Mg. Wyllie, alpha(1)-adrenoceptor selectivity: The North American experience, EUR UROL, 36, 1999, pp. 59-63

Authors: Langer, SZ Kirby, R Wyllie, MG Clarke, DE Andersson, KE Chapple, C",Brading,Michel,Schwinn

Citation: Sz. Langer et al., Role of alpha(1)-adrenoceptors in the future treatment of urological diseases, EUR UROL, 36, 1999, pp. 66-67